| # | Drug | Count |
|---|
| # | Drug | Count | Frequency |
|---|
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 599 |
| 1 | Kinase Inhibitor [EPC] | 486 |
| 2 | Corticosteroid [EPC] | 403 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 339 |
| 4 | Estrogen Receptor Antagonist [EPC] | 330 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 282 |
| 6 | RANK Ligand Inhibitor [EPC] | 247 |
| 7 | Benzodiazepine [EPC] | 237 |
| 8 | Microtubule Inhibitor [EPC] | 236 |
| 9 | Opioid Agonist [EPC] | 214 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 18 | 0.0166 |
| 1 | Estrogen Receptor Antagonist [EPC] | 330 | 0.0081 |
| 2 | Aromatase Inhibitor [EPC] | 599 | 0.0053 |
| 3 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 4 | Androgen Receptor Inhibitor [EPC] | 154 | 0.0021 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 139 | 0.0019 |
| 6 | Blood Viscosity Reducer [EPC] | 8 | 0.0018 |
| 7 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 8 | Calcitonin [EPC] | 5 | 0.0016 |
| 9 | Autologous Cellular Immunotherapy [EPC] | 9 | 0.0015 |